Meet us at BIO 2025 – Boston
Event Details
CPI is heading to BIO 2025 in Boston this June, where we’re available to connect with innovators, researchers and industry leaders from across the US and around the globe to discuss their cutting-edge innovations across pharma and MedTech.
If you’re working on next-generation biologics, drug-device combinations, or medtech innovations, let’s talk. Our experts are here to explore how we can support your journey from lab to market. We collaborate with industry partners to accelerate the development of their cutting-edge health technologies, helping to address global healthcare challenges and bring breakthrough solutions to market.
Advancing product and process innovation across pharma and medtech — collaboratively
At CPI, we help pharma and medtech companies bring their most ambitious ideas to life. Whether you’re scaling up a complex biologic, refining a minimally invasive device, or developing connected health technologies, we bring decades of deep technical expertise, world-class facilities, and a flexible, partnership-first approach.
About CPI
CPI is a technology innovation catalyst based in the UK, and working with companies globally. With over 20 years of experience helping HealthTech innovators bring transformative solutions to market. We collaborate with partners, including startups, SMEs, multinationals and academics, to deliver impact across the life sciences:
500+ scientists and engineers
$300M+ in cutting-edge innovation infrastructure
1500+ projects delivered, unlocking $4B in private R&D investment
Accelerating pharmaceutical product and process development
We help companies bridge the gap between discovery and clinical trials through:
Biologics process development and scale-up: End-to-end support from upstream to downstream, with integrated formulation capabilities.
Multimodal expertise: Including mRNA, viral vectors, nanomedicines, phages, live bacterial products, and more.
Flexible, IP-friendly collaboration models: Flexible terms and no locked-in platforms: usually the process is yours, portable and flexible.
mRNA process development and scale-up for personalised cancer vaccines and infectious disease applications, with scalable LNP formulation.
Biologics process development for scalable production of monoclonal antibodies and recombinant proteins using advanced upstream, downstream and analytical technologies.
Developing and scaling MedTech products
We specialize in supporting complex medtech development, including:
Instruments: Precision engineering, regulatory navigation, and scalable production
Assays and reagents: High-quality, scalable solutions that meet regulatory standards
Consumables: Designing intuitive, manufacturable components that drive adoption
Examples of our impact:
Fermentation-based scale-up of recombinant proteins and enzymes for IVD reagent production
Printed biosensors for chronic disease monitoring using advanced nano-inks and scalable manufacturing techniques
Meet us at BIO 2025
If you’re looking to accelerate your path to market and tap into world-class expertise and infrastructure, CPI is ready to help. We work with companies from the US and globally to turn R&D into a commercial reality, faster and with less risk.
Book a meeting with us
Dr. Alex Cole, Director of Market Strategy at CPI, will be attending BIO 2025 in Boston and is available for meetings throughout the conference. Check out his availability on the link below.
Book time with Alex Cole: BIO2025 Meeting or email Alex directly: alex.cole@uk-cpi.com
